1. 5,6-Dehydrokawain from Alpinia zerumbet promotes osteoblastic MC3T3-E1 cell differentiation
- Author
-
Keisuke Nishikawa, Masatoshi Watai, Takashi Mishima, Yoshiki Morimoto, Kazuhiro Fujita, Izumi Yoshida, Akio Watanabe, Shinkichi Tawata, Momochika Kumagai, and Teppei Harada
- Subjects
0301 basic medicine ,p38 mitogen-activated protein kinases ,Core Binding Factor Alpha 1 Subunit ,p38 Mitogen-Activated Protein Kinases ,Applied Microbiology and Biotechnology ,Biochemistry ,Bone resorption ,Cell Line ,Analytical Chemistry ,Mice ,03 medical and health sciences ,Osteogenesis ,Gene expression ,medicine ,Animals ,Humans ,Alpinia zerumbet ,RNA, Messenger ,Protein kinase A ,Molecular Biology ,Transcription factor ,Cell Proliferation ,Homeodomain Proteins ,Osteoblasts ,biology ,Plant Extracts ,Chemistry ,Macrophages ,Organic Chemistry ,Cell Differentiation ,Osteoblast ,General Medicine ,Alkaline Phosphatase ,biology.organism_classification ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,Gene Expression Regulation ,Pyrones ,Sp7 Transcription Factor ,Alpinia ,Alkaline phosphatase ,Rhizome ,Transcription Factors ,Biotechnology - Abstract
Bone homeostasis is maintained by balancing bone formation and bone resorption, but an imbalance between them is associated with various bone-related diseases such as osteoporosis and rheumatoid arthritis. We found that 5,6-dehydrokawain (DK) and dihydro-5,6-dehydrokawain (DDK), which were isolated as promising compounds from Alpinia zerumbet rhizomes, promote differentiation of osteoblastic MC3T3-E1 cells. DK and DDK increased the alkaline phosphatase activity and matrix mineralization of MC3T3-E1 cells. DK exerts larger effects than DDK. The gene expression of runt-related transcription factor 2 and osterix, which are essential transcription factors in the early period of osteoblast differentiation, was significantly increased by DK treatment. The mRNA level of distal-less homeobox 5 was also enhanced by DK treatment, and DK activated the p38 mitogen-activated protein kinase pathway. Therefore, DK may have clinical potential for preventing osteoporosis, and could be considered as a potential anabolic therapeutic agent.
- Published
- 2016
- Full Text
- View/download PDF